Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
8.68
-0.36 (-3.98%)
At close: May 06, 2025, 3:59 PM
8.91
2.71%
Pre-market: May 07, 2025, 08:10 AM EDT
-3.98% (1D)
| Bid | 8.91 |
| Market Cap | 838.26M |
| Revenue (ttm) | 169.12M |
| Net Income (ttm) | -48.83M |
| EPS (ttm) | -0.51 |
| PE Ratio (ttm) | -17.01 |
| Forward PE | 13.35 |
| Analyst | Buy |
| Ask | 9.3 |
| Volume | 3,793,252 |
| Avg. Volume (20D) | 1,147,336 |
| Open | 8.99 |
| Previous Close | 9.04 |
| Day's Range | 8.55 - 9.88 |
| 52-Week Range | 6.38 - 18.77 |
| Beta | 1.40 |
About AVDL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVDL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVDL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Avadel Pharmaceuticals has released their quartely earnings
on May 7, 2025:
Next Earnings Release
Avadel Pharmaceuticals is scheduled to release its earnings on May 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-1.57%
Avadel Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
5 months ago
-8.59%
Avadel Pharmaceuticals shares are trading lower after HC Wainwright maintained a Buy rating on the stock and cut its price target from $27 to $25.
2 months ago · seekingalpha.com
Avadel Pharmaceuticals plc (AVDL) Q4 2024 Earnings Call TranscriptAvadel Pharmaceuticals plc (NASDAQ:AVDL ) Q4 2024 Earnings Conference Call March 3, 2025 8:30 AM ET Company Participants Austin Murtagh - Precision AQ Gregory Divis - Chief Executive Officer Thomas Mc...
